Clinical trial
Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial
NCT00497172 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00497172 |
|---|---|
| Title | Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial |
| Official title | An Italian Multicenter, Randomized, Single Blind Study of the Sirolimus Eluting Stent in the Treatment Of Diabetic Patients With De Novo Coronary Artery Lesions |
| Acronym | DESSERT |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER Sirolimus-eluting stent, Bx SONIC bare metal stent |
| Enrollment | 150 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Apr 1, 2009 |
| First posted | Jul 6, 2007 |
| Last update posted | Feb 4, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: